Showing results (51-60 of 230) with videos related to
Sort By:
Pageof 23
Cancer Research|December 1, 1986
Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humansJ M Strong, J M Collins, C Lester, et al.Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II)P E Gormley, D Gangji, J H Wood, et al.Cancer Research|January 1, 1985
Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formationJ Jolivet, D E Cole, J S Holcenberg, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1983
Pharmacokinetics of 6-mercaptopurine (6MP) in the monkey. I. Disposition from plasma and cerebrospinal fluid following iv bolusP K Narang, D C Chatterji, D O'Neill, et al.Investigational New Drugs|May 1, 1993
Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primateR L Heideman, C McCully, F M Balis, et al.Infection and Immunity|December 1, 1974
Lipid peroxidation in the killing of phagocytized pneumococciS B Shohet, J Pitt, R L Baehner, et al.Cancer Research|August 1, 1988
Preclinical pharmacology of arabinosyl-5-azacytidine in nonhuman primatesR L Heideman, F M Balis, C McCully, et al.Blood|November 1, 1978
Acute lymphoblastic leukemia followed by chronic myelocytic leukemiaG Tosato, J Whang-Peng, A S Levine, et al.Cancer Research|September 1, 1985
Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell linesS Zimm, G E Johnson, B A Chabner, et al.Problemy Medycyny Wieku Rozwojowego|January 1, 1990
[Infectious complications from intraventricular route of administration in cancer patients]D Perek, J R Commers, D G Poplack, et al.Pageof 23